not approved for human, clinical, or veterinary use Available Dosages 10 mg, 20 mg (18 mg) 5-Amino-1MQ is a synthetic research compound studied for its ability to inhibit nicotinamide N-methyltransferase (NNMT)
The proposed chain of effects looks like this: NNMT inhibited nicotinamide is no longer inactivated by methylation and becomes available for conversion to NAD+
It also controls blood sugar levels, helping to reduce cravings
Unlike single-pathway compounds, retatrutide simultaneously activates three distinct receptor systems: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors [3]
Why This Concentration: The Small Cat Precision Argument In cats under 2.5 kg, high-concentration formulations produce injection volumes too small for reliable measurement
Studies in animal models of neurological damage document not only preservation of existing neurons but recovery of function suggesting actual repair and reconnection of damaged neural circuits through enhanced synaptogenesis and neurite outgrowth